Antibacterial Activity of Quinupristin/Dalfopristin
- 1 January 1996
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 51 (1) , 31-37
- https://doi.org/10.2165/00003495-199600511-00007
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Bactericidal activity and kinetics of RP 59500 in a mouse model of Staphylococcus aureus septicaemiaJournal of Antimicrobial Chemotherapy, 1995
- Pharmacodynamics of RP 59500 alone and in combination with vancomycin against Staphylococcus aureus in an in vitro-infected fibrin clot modelAntimicrobial Agents and Chemotherapy, 1995
- In vitro activities of a streptogramin (RP59500), three macrolides, and an azalide against four respiratory tract pathogensAntimicrobial Agents and Chemotherapy, 1995
- RP 59500, a new streptogramin highly active against recent isolates of North American staphylococciDiagnostic Microbiology and Infectious Disease, 1993
- Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacinAntimicrobial Agents and Chemotherapy, 1992
- In vitro antistaphylococcal activity and testing of RP 59500, a new streptogramin, by two methodsAntimicrobial Agents and Chemotherapy, 1992
- New forms and new needs may make macrolides antibiotics of the decade.1992
- In-vitro antibacterial activity of RP 59500, a semisynthetic streptogramin, against Streptococcus pneumoniaeJournal of Antimicrobial Chemotherapy, 1992
- Studies of RP 59500 in vitro and in a rabbit model of aortic valve endocarditis caused by methicillin-resistant Staphylococcus aureusJournal of Antimicrobial Chemotherapy, 1992
- In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococciAntimicrobial Agents and Chemotherapy, 1991